| 查看: 1673 | 回复: 7 | ||||
| 当前主题已经存档。 | ||||
[交流]
辗转于Nature 期刊系列间……
|
||||
|
写了一篇文章。 先是投到了Nature上，Nature编辑回信说，文章专业性太强，建议投到一个比较专业性的期刊上。 于是改投 Nature Medicine，主编给的意见还不错，直接推荐到 Nature Reviews Cancer上面（用编辑部的稿件转移系统）。 于是投稿到Nature Reviews Cancer上面。结果一个多月以后，又被拒。 Nature 的这些子期刊之间的编辑之间，还是不一定互相买账的…… 这些是拒稿信： 拒信1，来自Nature： Dear Dr Ma Thank you for offering us your paper entitled "×××××", which we must decline on editorial grounds. We do not doubt the technical quality of your study or its interest to others working in this and related areas of research. However, after consideration, we have concluded that this paper will be of insufficiently immediate interest to researchers in a broad range of other disciplines to justify publication in Nature. I am sorry that on this occasion we cannot be more encouraging. Yours sincerely Barbara Marte 拒信2，来自Nature Medicine： Dear Dr. Ma, Thank you for asking us to consider your proposed Manuscript "×××××" (×××). We have given careful consideration to it and concluded that it would not be well suited to Nature Medicine. Because many articles are submitted and we are only able to consider publishing a few of these, the competition for space is quite fierce. Each proposal is carefully evaluated by the editorial team, and only those that are considered of likely broad interest and of high impact are invited. Papers may fall short of consideration on a number of editorial grounds. For example, they may be too specialized, unlikely to appeal to a broad sample of the biomedical community or they may not adequately address subjects that are likely to interest and be accessible to our readers. Moreover, commentaries are usually commissioned by the editors to cover a specific field of interest for the journal. In this particular case, we think that the paper might be more suitable to a journal specialized in cancer. In fact, if I may, I'd like to suggest the possibility of transferring your submission to our sister journal Nature Reviews Cancer using the link at the bottom of this letter. Being editorially independent, I cannot guarantee that they'll be enthused by the submission, but I'd say it's a possibility worth considering. Nevertheless, thank you very much for giving us the opportunity to consider your work. I am sorry that we cannot be more positive on this occasion and hope you are soon able to interest another journal in the work. Sincerely, Juan Carlos Lopez, Ph.D Chief Editor Nature Medicine 第三个拒信，来自Nature Reviews Cancer： Dear Dr Ma, Thank you for sending a proposal entitled "×××××" to Nature Reviews Cancer. We have now had the chance to take a look at your proposal and I'm afraid we've decided not to commission an article on this topic. Thank you for taking the time to contact us with your suggestion and for your interest in Nature Reviews Cancer. best wishes, Patrick Goymer, DPhil Assistant Editor Nature Reviews Cancer 2006 ISI Impact Factor 31.583 |
回复此楼» 收录本帖的淘帖专辑推荐
 可以考虑的杂志 |
» 猜你喜欢
国社科又开始会评了，不知道这次命运如何
已经有13人回复
-
麻烦专家们看看评委们的意见（F口面上）
已经有13人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有6人回复
-
为什么资助数各大高校都创新高，自己申请怎么就这么难
已经有15人回复
-
科研人应该花精力去思考如何解决问题，而不是去凝练问题
已经有14人回复
-
要骂人了，新模版改版就是要淡化问题凝练这种虚的东西，结果有个评委还在说凝练得不够
已经有17人回复
-
基金系统什么内容也没有
已经有10人回复
-
学科评审组评审是指会评吗？
已经有5人回复
-
面上函评意见出来了，像什么等级？
已经有17人回复
2楼2008-05-01 10:15:41
3楼2008-05-01 10:21:18
kanglangyu
铜虫 (正式写手)
- 应助: 0 (幼儿园)
- 金币: 360.5
- 散金: 866
- 红花: 3
- 帖子: 330
- 在线: 213.1小时
- 虫号: 454464
- 注册: 2007-11-09
- 性别: GG
- 专业: 肿瘤发生
4楼2008-05-01 11:27:57
5楼2008-05-01 19:24:04
 本帖仅楼主可见 |
6楼2008-05-10 11:50:22
30